Novel substituted benzamide based inhibitors, their use in therapy, pharmaceutical compositions comprising the compounds, the use of said compounds in the manufacture of medicaments, and therapeutic methods comprising the administration of said compounds are described. The present compounds modulate the activity of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) and are accordingly useful in the treatment of diseases in which such a modulation is beneficial, such as the metabolic syndrome.
本发明涉及一种新型的取代苯甲酰胺基
抑制剂,其在治疗中的使用,包括该化合物的制药组合物,以及在制造药物时使用该化合物的方法和包含该化合物的治疗方法。这些化合物可以调节11β-羟基类
固醇脱氢酶1型(11βH
SD1)的活性,因此在治疗代谢综合征等需要这种调节有益的疾病中有用。